0.416  -0.043 (-9.37%)		03-19 16:00
Open: 0.45 High: 0.45 Volume: 85,700		Pre. Close: 0.459 Low: 0.4146 Market Cap: 2(M)

Short term
Mid term
Targets	6-month :	0.54	1-year :	0.64
Resists	First :	0.46	Second :	0.54
Pivot price	0.42
Supports	First :	0.39	Second :	0.34
MAs	MA(5) :	0.43	MA(20) :	0.41
	MA(100) :	0.62	MA(250) :	1.12
MACD	MACD :	0	Signal :	-0.1
%K %D	K(14,3) :	63.4	D(3) :	75.1
RSI	RSI(14): 48.1
52-week	High :	2.81	Low :	0.34

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ AMIX ] has closed above bottom band by 40.9%. Bollinger Bands are 72.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 29 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	0.45 - 0.45	0.45 - 0.45
Low:	0.41 - 0.41	0.41 - 0.41
Close:	0.41 - 0.42	0.42 - 0.42

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.

Sat, 17 Jan 2026
Autonomix Medical Receives Nasdaq Minimum Bid Price Notice - The Globe and Mail

Fri, 16 Jan 2026
Autonomix Medical receives Nasdaq notice for minimum bid price deficiency - Investing.com

Fri, 09 Jan 2026
Autonomix (AMIX) Stock: Clinical Subgroup Analysis Supports Potential Palliative Impact of RF Denervation - parameter.io

Tue, 30 Dec 2025
Autonomix Medical (AMIX) Stock: Skyrockets Following Major Patent Approval - parameter.io

Tue, 29 Jul 2025
AMIX Stock Price and Chart — NASDAQ:AMIX - TradingView

Thu, 22 May 2025
Should I buy Autonomix Medical, Inc. (AMIX) - Zacks Investment Research

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	11 (M)
Shares Float	11 (M)
Held by Insiders	4 (%)
Held by Institutions	2.5 (%)
Shares Short	489 (K)
Shares Short P.Month	659 (K)

EPS	-3.16
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0.75
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-99 %
Return on Equity (ttm)	-188.8 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	-1.54
Qtrly Earnings Growth	0 %
Operating Cash Flow	-12 (M)
Levered Free Cash Flow	-6 (M)

PE Ratio	-0.14
PEG Ratio	0
Price to Book value	0.55
Price to Sales	0
Price to Cash Flow	-0.4

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.